Promising New Migraine Drug
For those unfortunate people who suffer from debilitating migraines and who don’t get relieve from Triptans (Imitrex, Maxalt, Frova, etc.) or can’t take them due to heart or blood pressure problems:
New experimental drug, currently named MK-0974, could be making it’s way to the pharmacy near you as soon as 2009. It still needs an approval from FDA but the noises coming from medical and scientific crowds are promising.
Those studies conducted showed no serious side effects but some of the minor ones might include drowsiness, nausea and dizziness. Interestingly, they didn’t compound in severity as the dosage increased. Advantageously, the migraine blocking effect of this new wonder drug MK-0974 lasts for approximately 24 hours, much longer than with most triptans – a great piece of news for migraine sufferers.
Scientifically speaking, “MK-0974 is an antagonist of the receptor for CGRP”. In contrast, triptans are serotonin antagonists, so they act in different ways but both relieve the pain of migraines.
0